GLP-1 drugs and kidney stones — is there a link?

Short answer: There is no strong evidence that GLP-1 drugs (like Ozempic, Wegovy, or the GLP-1/GIP drug tirzepatide) cause kidney stones. In fact, some early observational studies suggest the risk may be lower, not higher, in people taking them — but that evidence is limited and not proven. The practical concerns are staying hydrated and, separately, the higher stone risk that comes with weight-loss surgery (a different treatment).


What we do — and don’t — know.

  • Direct cause? GLP-1 drugs are not known to cause kidney stones directly. Kidney stones form when urine becomes concentrated or chemically prone to crystallizing; the drugs themselves don’t have a clear stone-forming mechanism.
  • Some data point the other way. Several large real-world (observational) studies have reported a lower rate of kidney stones in people taking GLP-1 drugs. For example, in people with obesity and a prior stone history, one analysis found fewer stone events on a GLP-1 drug than off it (about 27% vs 43%), and lower rates of first-time stones as well. Observational studies can’t prove cause and effect — this remains an open question — but they argue against a stone-raising effect, and possibly toward a protective one (perhaps through weight loss and lower urinary oxalate).

Where a real stone risk does come in.

  • Dehydration. The stomach side effects of these drugs — nausea, vomiting, diarrhea — can leave you under-hydrated, and low fluid intake concentrates the urine, which can favor stones. This is a good, simple reason to keep your fluids up, especially if you’ve had stones before.
  • Weight-loss (bariatric) surgery — a separate treatment. This is the clearer stone story. Malabsorptive procedures (like Roux-en-Y gastric bypass) can raise the body’s absorption of oxalate, leading to enteric hyperoxaluria and a higher risk of oxalate kidney stones — and, rarely, oxalate deposits in the kidney. If your weight-loss plan includes surgery, ask specifically about stone prevention. (This risk is about the surgery, not the GLP-1 drug.)

Practical takeaways.

  1. Hydrate — aim to keep your urine pale, and drink more when you have any nausea, vomiting, or diarrhea.
  2. If you’re a stone former, tell your clinician; they may check your urine chemistry and give targeted advice.
  3. If weight-loss surgery is on the table, ask about oxalate and stone prevention specifically.
  4. Don’t avoid a GLP-1 drug solely out of fear of stones — the evidence does not support that fear, and the drug may even be neutral or protective.

Related: Semaglutide (Ozempic/Wegovy) and Your Kidneys and Tirzepatide (Mounjaro/Zepbound) and Your Kidneys.


Related questions

Can Ozempic or Wegovy give you kidney stones? There’s no clear evidence they cause stones, and some data suggest a lower risk. The main thing to manage is staying hydrated if the drug gives you stomach side effects.

Does weight-loss surgery cause kidney stones? Malabsorptive procedures (like gastric bypass) can raise oxalate absorption and the risk of oxalate stones. Ask your surgical team about prevention if you’re a stone former.

I’ve had kidney stones before — can I still take a GLP-1 drug? Usually yes. Focus on hydration and let your clinician know your stone history so they can advise on urine testing and prevention.

📬 Get two free guides + stay current. Join the newsletter and instantly get our two free PDF guides — Sick-Day Rules for Weight-Loss Injections and 5 Questions to Ask Before Starting a Weight-Loss Injection — plus a short monthly email when a new study actually changes how we think about weight-loss medication and your kidneys. No hype, no selling.

Get the free guides →


Written and medically reviewed by Dr. Amir S. Naderi, MD, FASN. Last updated: July 8, 2026. Educational information only — not medical advice. Never change or stop a prescribed medication without talking to your doctor.